Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
Sungji Moon, Hae-Young Lee, Jieun Jang, Sue K. Park
J Prev Med Public Health. 2020;53(6):476-486. Published online 2020 Nov 3 DOI: https://doi.org/10.3961/jpmph.20.405
Citations to this article as recorded by 
Association between Statins and Incidence of Cancer in Patients with Dyslipidemia Using Large-Scale Health Insurance Claims Data
Ayako Maeda-Minami, Masayuki Takagi, Yasunari Mano, Hideki Ishikawa, Yutaka Matsuyama, Michihiro Mutoh
Cancer Prevention Research.2023; 16(1): 37. CrossRef
Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
Zexu Wang, Lingyun Wei, Cheng Yin, Wang Li, Bing Wan
Journal of Personalized Medicine.2023; 13(2): 243. CrossRef
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cancer Risk: An Updated Meta-Analysis of Observational Studies
Kayeong Shin, Jiwoo Yang, Yeuni Yu, Eunjeong Son, Kihun Kim, Yun Hak Kim
SSRN Electronic Journal .2022;[Epub] CrossRef
The Effect of Local Renin Angiotensin System in the Common Types of Cancer
Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi, Tlili Barhoumi
Frontiers in Endocrinology.2021;[Epub] CrossRef